On July 7, 2022, Generon (Shanghai) Corporation Ltd. closed the transaction. Post the transaction, Sino Biopharmaceutical Limited and Yifan Pharmaceutical (Hong Kong) Co., Ltd. now hold 2.44% and 66.92% stakes in the company respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 HKD | -1.61% | +6.62% | -11.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.82% | 7.3B | |
+30.38% | 684B | |
+29.54% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.30% | 240B | |
+9.43% | 208B | |
-7.16% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Generon Corporation Ltd. announced that it has received $70.000203 million in funding from Sino Biopharmaceutical Limited, Yifan Pharmaceutical (Hong Kong) Co., Ltd.